Site icon OncologyTube

VIDEO 2020 TTF ALK/ROS SESSION QA PANEL ROS1 Patients – Chemo After Resistance to Inhibitor Therapy?

Videos from the 2020 Targeted Therapies Patient Forum are still available!

This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.

The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer.

Advertisement

In this video from the ALK/ROS session from the event, the panel discusses whether ROS1+ patients should go on chemo after developing resistance to TKIs.

We thank our sponsors for their support of this event! #AstraZeneca #Lilly #Novartis #Takeda #FoundationMedicine #BoehringerIngelheim #BlueprintMedicines #Genentech

Access to the full 2020 agenda can be found here: https://bit.ly/39131em
Full bios for attending faculty can be found here: https://bit.ly/2M0FVLH

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Exit mobile version